Transcatheter Closure Of Atrial Septal Defect With Atrial Septal Occluder In Patients With Nickel Allergy

Abstract

Presently described is transcatheter closure of atrial septal defect with atrial septal occluder (ASO) device in a patient with nickel allergy. Patients with metal allergy who will undergo nitinol device implantation should be tested for possible nickel hypersensitivity. ASO device and treatment strategy (percutaneous or surgical) should be selected according to allergy test result.

Surgical removal of atrial septal defect closure device due to systemic allergic reaction to nickel: A case report

“…[10][11][12] In addition, successful transcatheter ASD or PFO closure in patients with a known nickel allergy has been also described in the literature. [4,13] Nickel allergy is quite common in the adult population. Hypersensitivity to nickel may lead to localized or systemic reactions.…”

“…Hypersensitivity reactions can be seen in patients allergic to nickel; however, it does not constitute a definite contraindication for percutaneous closure. [ 4 ] If percutaneous closure is planned in patients with a known nickel allergy, devices with less nitinol content such as GORE® HELEX® Septal Occluder (W. L. Gore and Associates, Inc., Flagstaff, AZ, USA), CardioSEAL™ (NMT Medical, Inc., Boston, MA, USA) and Atriasept™ (Cardia, Inc., Eagan, MN, USA) can be used alternatively. However, it should be noted that all current approved ASD and PFO closure devices contain nitinol.…”

“…[ 10 - 12 ] In addition, successful transcatheter ASD or PFO closure in patients with a known nickel allergy has been also described in the literature. [ 4 , 13 ]…”